These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26537759)

  • 21. Antibody glycoengineering strategies in mammalian cells.
    Wang Q; Chung CY; Chough S; Betenbaugh MJ
    Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies.
    Tytgat HLP; Lin CW; Levasseur MD; Tomek MB; Rutschmann C; Mock J; Liebscher N; Terasaka N; Azuma Y; Wetter M; Bachmann MF; Hilvert D; Aebi M; Keys TG
    Nat Commun; 2019 Nov; 10(1):5403. PubMed ID: 31776333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-glycosylation engineering of biopharmaceutical expression systems.
    Jacobs PP; Callewaert N
    Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q; Wang T; Zhang R; Yang S; McFarland KS; Chung CY; Jia H; Wang LX; Cipollo JF; Betenbaugh MJ
    Biotechnol Bioeng; 2022 Jan; 119(1):102-117. PubMed ID: 34647616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for Engineering Protein N-Glycosylation Pathways in Mammalian Cells.
    Wang Q; Stuczynski M; Gao Y; Betenbaugh MJ
    Methods Mol Biol; 2015; 1321():287-305. PubMed ID: 26082230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits.
    Chen R
    Microb Cell Fact; 2015 Dec; 14():197. PubMed ID: 26655367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
    Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
    Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical inhibitors of hexokinase-2 enzyme reduce lactate accumulation, alter glycosylation processing, and produce altered glycoforms in CHO cell cultures.
    Naik HM; Kumar S; Reddy JV; Gonzalez JE; McConnell BO; Dhara VG; Wang T; Yu M; Antoniewicz MR; Betenbaugh MJ
    Biotechnol Bioeng; 2023 Sep; 120(9):2559-2577. PubMed ID: 37148536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Producing Biologics with Defined N-Glycosylation in Plants.
    Esqueda A; Chen Q
    Methods Mol Biol; 2023; 2597():235-250. PubMed ID: 36374425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered CHO cells for production of diverse, homogeneous glycoproteins.
    Yang Z; Wang S; Halim A; Schulz MA; Frodin M; Rahman SH; Vester-Christensen MB; Behrens C; Kristensen C; Vakhrushev SY; Bennett EP; Wandall HH; Clausen H
    Nat Biotechnol; 2015 Aug; 33(8):842-4. PubMed ID: 26192319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering mammalian cells to produce plant-specific N-glycosylation on proteins.
    Larsen JS; Karlsson RTG; Tian W; Schulz MA; Matthes A; Clausen H; Petersen BL; Yang Z
    Glycobiology; 2020 Jul; 30(8):528-538. PubMed ID: 32039452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial glycoengineering: Cell-based and cell-free routes for producing biopharmaceuticals with customized glycosylation.
    Palma JA; Bunyatov MI; Hulbert SW; Jewett MC; DeLisa MP
    Curr Opin Chem Biol; 2024 Aug; 81():102500. PubMed ID: 38991462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial glycobiotechnology: A biosynthetic route for the production of biopharmaceutical glycans.
    Paliya BS; Sharma VK; Tuohy MG; Singh HB; Koffas M; Benhida R; Tiwari BK; Kalaskar DM; Singh BN; Gupta VK
    Biotechnol Adv; 2023 Oct; 67():108180. PubMed ID: 37236328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging technologies for making glycan-defined glycoproteins.
    Wang LX; Lomino JV
    ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controllability analysis of protein glycosylation in CHO cells.
    St Amand MM; Tran K; Radhakrishnan D; Robinson AS; Ogunnaike BA
    PLoS One; 2014; 9(2):e87973. PubMed ID: 24498415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A; Shanmugam D; Gadgil M
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
    Strasser R
    Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupling CRISPR interference with FACS enrichment: New approach in glycoengineering of CHO cell lines for therapeutic glycoprotein production.
    Glinšek K; Kramer L; Krajnc A; Kranjc E; Pirher N; Marušič J; Hellmann L; Podobnik B; Štrukelj B; Ausländer D; Gaber R
    Biotechnol J; 2022 Jul; 17(7):e2100499. PubMed ID: 35481906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.